Previous Investments

Previous Investments1

Company Marketer / Counterparty Product Initial Investment Date
Vertex Johnson & Johnson Telaprevir October 2009
Royalty Trust Astellas Lexiscan December 2009
CDC BioDelivery Sciences Ineternational / Meda AB Onsolis December 2009
MedPro Safety Products Greiner Bio-One Vacuette Safety System October 2010
Fosamprenavir Royalty, L.P. ViiV Healthcare / GSK Lexiva December 2010
RS Royalty Sub LLC Pfizer Lyrica January 2011
CPEX Pharmaceuticals Auxilium Testim April 2011
Paradigm Spine, LLC None coflex June 2011

1. The investments listed in the table include all of Athyrium’s previously recommended investments that meet the criteria of our current mandates and investment strategies.